Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ligand Pharmaceuticals

109.39
+0.24000.22%
Post-market: 109.390.00000.00%16:05 EDT
Volume:81.14K
Turnover:8.91M
Market Cap:2.11B
PE:-496.22
High:111.42
Open:110.85
Low:108.50
Close:109.15
Loading ...
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2022

Major Issues Report

8-K - Current report
Jan 14, 2022

Major Issues Report

8-K - Current report
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 16, 2021

Major Issues Report

8-K - Current report
Aug 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2021

Major Issues Report

8-K - Current report
Jul 21, 2021

Major Issues Report

8-K - Current report
Jul 14, 2021

Major Issues Report

8-K - Current report
Jun 07, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2021

Major Issues Report

8-K - Current report
Feb 24, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals